Fundraising FoxTakethesis
6 known investors
Find your way into Takethesis
Sign up to find every way you can get introduced to Takethesis
- Your email: who you already know at Takethesis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Takethesis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Clarity is a nootropic supplement from Thesis formulated with ingredients such as CDP Choline, Lion's Mane, Panax Ginseng, and caffeine to support focus, mental clarity, and neuroplasticity. It is sold direct-to-consumer for people seeking improved cognitive performance.
Also known as Take Thesis · Thesis
Investors · 6
How we know: Break Trail Ventures's portfolio page · Not right? Tell us
How we know: Evolution VC Partners's portfolio page · Not right? Tell us
How we know: Studio Management's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Company profile
researched Aug 2026Thesis (operating at takethesis.com) develops and sells nootropic supplement formulas intended to support cognitive function. The company organizes its catalog around distinct outcome-based formulas: Clarity (concentration and focus), Motivation (brain energy and awareness), Stress Reset (calm and resilience), and Neuroprotection (memory and long-term brain health). Each formula is offered on a subscription basis with pricing starting at $59 per month.
The company's stated approach centers on neuroplasticity — the premise that appropriately stimulated brains generate new neurons and strengthen synaptic connections — and on targeting neurotransmitters and hormones associated with focus, learning, motivation, memory, stress resilience and long-term brain health. Thesis describes its formulation process as data-driven, relying on iterative testing, and reports nine years of research, more than 127 ingredients tested and more than 30 beta tests.
Business model
Direct-to-consumer sale of nootropic supplement formulas via the company's website, structured as monthly subscriptions starting at $59 per formula, with an introductory 50% discount on the first month.
Recurring subscription revenue from monthly supplement shipments, with formula prices starting at $59 per month.
Traction
The company's site displays aggregate customer ratings of 4.6-4.7 out of 5 across its formulas, with 3,321 reviews for Clarity, 1,922 for Motivation, 920 for Neuroprotection and 634 for Stress Reset.
▸Full profile — market position, technology, go-to-market
Market position
Positions itself on personalization to the individual (matching customers to a specific formula) and on iterative, test-driven formulation rather than a single general-purpose product.
Technology
Nootropic formulations built around ingredients selected to act on neurotransmitters and hormones linked to focus, learning, motivation, memory and stress resilience, developed through iterative testing cycles; the company reports 127+ ingredients tested across 30+ beta tests.
Go-to-market
Online direct-to-consumer channel with an onboarding flow that matches customers to a recommended formula ("Find Your Formula"), supported by promotional first-month discounting and published customer reviews and testimonials.
Consumers seeking to improve focus and productivity, increase energy and motivation, manage stress, or support memory and long-term brain health.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Takethesistakethesis.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Takethesis do?
- Thesis sells subscription nootropic supplement formulas targeting focus, energy, stress resilience, memory and brain health.
- Who are Takethesis's investors?
- Takethesis's investors include Break Trail Ventures, Evolution VC Partners, REDO Ventures, Studio Management, ECP Growth, Trust Ventures.